CD274 and head and neck squamous cell carcinoma: These results should be interpreted with caution, given that the HNSCC cohort was heterogeneous; it included cutaneous carcinomas which may have higher response rates to anti-PD-(L)-1 immunotherapy, and enrichment for higher PD-L1 expression could not be excluded.